| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,682 |
3,086 |
$1.21M |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,838 |
2,166 |
$838K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,210 |
2,278 |
$703K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,810 |
1,352 |
$695K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,385 |
826 |
$340K |
| 80053 |
Comprehensive metabolic panel |
3,844 |
3,283 |
$236K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,248 |
1,083 |
$231K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,681 |
1,512 |
$147K |
| 80050 |
General health panel |
619 |
591 |
$135K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,880 |
2,487 |
$119K |
| 36415 |
Collection of venous blood by venipuncture |
6,328 |
5,169 |
$118K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
927 |
786 |
$103K |
| 97113 |
|
660 |
188 |
$74K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
335 |
109 |
$73K |
| 80061 |
Lipid panel |
1,033 |
996 |
$66K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,117 |
1,080 |
$54K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
484 |
421 |
$38K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
298 |
234 |
$34K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
369 |
144 |
$32K |
| 81001 |
|
864 |
761 |
$29K |
| 85027 |
|
875 |
719 |
$28K |
| 85007 |
|
922 |
758 |
$22K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
338 |
301 |
$18K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
240 |
217 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
281 |
250 |
$16K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
340 |
316 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
136 |
109 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
225 |
205 |
$10K |
| 97162 |
|
72 |
68 |
$9K |
| 84484 |
|
136 |
106 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
61 |
60 |
$7K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
36 |
34 |
$6K |
| 97014 |
|
139 |
51 |
$6K |
| 97597 |
|
70 |
28 |
$6K |
| 81003 |
|
180 |
154 |
$3K |
| 87186 |
|
42 |
38 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
14 |
14 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
29 |
26 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
29 |
24 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
96 |
70 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
27 |
26 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
58 |
43 |
$2K |
| 83690 |
|
40 |
37 |
$2K |
| 97116 |
|
31 |
12 |
$1K |
| 97161 |
|
12 |
12 |
$1K |
| T1015 |
Clinic visit/encounter, all-inclusive |
742 |
663 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
16 |
12 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
29 |
28 |
$1K |
| 83605 |
|
19 |
15 |
$1K |
| 0012A |
|
36 |
33 |
$946.26 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15 |
15 |
$878.50 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
102 |
79 |
$875.09 |
| 0011A |
|
39 |
39 |
$864.99 |
| 0002A |
|
30 |
29 |
$755.72 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14 |
13 |
$684.56 |
| 87400 |
|
15 |
13 |
$662.47 |
| 85652 |
|
33 |
25 |
$633.62 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15 |
13 |
$589.64 |
| 0001A |
|
20 |
20 |
$503.55 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
30 |
26 |
$208.16 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
36 |
27 |
$189.10 |
| 97164 |
|
15 |
12 |
$188.07 |
| 85610 |
|
13 |
12 |
$141.92 |
| 91300 |
|
71 |
56 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12 |
12 |
$0.00 |
| 91301 |
|
85 |
81 |
$0.00 |